Semaglutide is linked to a reduced risk for Alzheimer’s disease-related dementia in patients with diabetes vs other ...

Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications ...

The study, carried out by experts from the University of Nottingham and funded by the National Institute for Health Research ...

A new study from Case Western Reserve School of Medicine suggests that GLP-1 weight loss drugs like Ozempic and Wegovy could ...

New immunotherapy drugs offer some hope in the fight against Alzheimer's disease but they're too pricey for the NHS ...

A groundbreaking analysis from leading British universities has uncovered surprising links between everyday medications and ...

After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

Cutting-edge research explores how social robots and AI can revolutionize dementia care by detecting early signs of cognitive ...

A new study has found that regular use of certain types of commonly-prescribed drugs can increase the risk of dementia in ...

Too often as patients age, doctors pile on prescriptions. The practice, known as polypharmacy, can be dangerous at any age but is particularly hazardous for elderly people, from raising the risk of ...

They were designed to treat diabetes, then prescribed for weight loss, and now—as researchers are finding—they might hold the secret to staving off Alzheimer’s, too.

Music and Memory” examines how music can reduce agitation in people with living with Alzheimer’s and Parkinson’s.